News

According to researchers at Duke University Medical Center, the tool demonstrates the potential for a non-invasive and inexpensive way to diagnose a common precursor of Alzheimer’s disease.

The company has completed evaluation on candidates and selected a single drug candidate to move forward into clinical trials.

The 2023 41st annual meeting of the American Society of Retina Specialists (ASRS) will run from Thursday, July 27 to Tuesday, August 1 in Seattle, a city filled with sightseeing, museums, and great food to explore.

The skills highlighted during the session are some of the most important tools in an ophthalmologist’s toolbelt and learning and practicing them early, even as a medical student, is crucial.

The Kansas-based company specializes in ophthalmic surgical equipment and services.

CT1812 is an experimental, oral therapy for the treatment of geographic atrophy secondary to dry age-related macular edema.

ASRS is an international, state-or-the-art event offering something for everyone: scientific papers, posters, panel discussions on controversial issues and techniques, award lectures, a Retina Case Conference, the 25th Annual Film Festival, international symposia, and subspecialty review courses.

Investigators set out to evaluate how well an AI system works when integrated into a handheld smartphone-based retinal camera to screen patients for DR using 1 retinal image in each eye.

According to the company, VRDN-001 data demonstrated clinically meaningful and rapid improvement in signs and symptoms of chronic TED at week 6 after receiving two infusions of VRDN-001 10 mg/kg or 3 mg/kg.

Researchers investigated the relationship between visual functioning measured using the National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) and mortality in patients with various stages of AMD.

While these injections are the standard treatment for this patient population, the investigators found a subgroup of patients who had severe visual loss between 2 consecutive intravitreal injections.

American Academy of Ophthalmic Professionals members will enjoy expanded opportunities for career advancement and access to the most up-to-date information in the field, including a new technician learning track at the Academy’s annual meeting in San Francisco this November.

According to the company, the financing will advance novel treatments for glaucoma and other chronic ophthalmic diseases by supporting multiple US clinical trials of its drug delivery platform.

Severe ocular surface and corneal damage an unseen public health burden.

In the sport, which is a hybrid of badminton, ping-pong and tennis, players use a plastic-perforated ball, slightly heavier than a whiffle ball, and wooden or composite paddles that are about twice the size of ping-pong paddles, with a high potential for eye injuries.

Take a look at a review of the highlights and hottest stories from Ophthalmology Times during the week of July 2, 2023.

The company announced its contract manufacture, NextPharma, completed filling of the drug materials into strips of 10 single-use vials for use in upcoming glaucoma trial.

In the sport, which is a hybrid of badminton, ping-pong and tennis, players use a plastic-perforated ball, slightly heavier than a whiffle ball, and wooden or composite paddles that are about twice the size of ping-pong paddles, with a high potential for eye injuries.

The Icahn School of Medicine at Mount Sinai opened the Center for Ophthalmic Artificial Intelligence and Human Health, which is dedicated to advancing artificial intelligence to offer faster diagnosis and treatment.

The India-based pharmaceutical company is taking its first steps into ophthalmology with the announcement.

Bausch + Lomb has agreed to acquire the Blink product line for $106.5 million.

A new study found an approach that identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam.

Since 2014 when a sheet of retinal pigment epithelial cells derived from iPS cells was transplanted into patients with age-related macular degeneration, clinical trials have been conducted with various cell types derived from iPS cells.

In a study of 1.7 million older Americans by a team of researchers from the University of Toronto, those living in counties with an average temperature of 60°F or above had an increased chance of suffering serious vision impairment than those in cooler counties.

A study found the approach identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam.

Surgeon discusses latest trends for treating cornea.

Trainees learn to recognize key pathologies seen in fundus examinations, OCT images